RESOLUTION THERAPEUTICS
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
RESOLUTION THERAPEUTICS
Industry:
Biopharma Biotechnology Life Science
Founded:
2017-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Total Employee:
11+
Status:
Active
Total Funding:
26.6 M GBP
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
AffyImmune Therapeutics
AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Helperby Therapeutics
Helperby Therapeutics (Helperby) is a biopharmaceutical company dedicated to developing the next generation of lifesaving antibiotics.
Kither Biotech
Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases
Reflection Therapeutics
Reflection Therapeutics is developing cell therapy technology against neuroinflammation across the board.
Current Advisors List
Current Employees Featured
Founder
Investors List
Syncona Partners LLP
Syncona Partners LLP investment in Series A - Resolution Therapeutics
More informations about "Resolution Therapeutics" on Search Engine
Resolution Therapeutics to Participate in the Jefferies Global ...
3 days ago Resolution Therapeutics is a clinical-stage biopharmaceutical company pioneering macrophage cell therapy for transformative outcomes in inflammatory organ …See details»
Resolution Therapeutics | LinkedIn
Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive …See details»
Resolution Therapeutics to Participate in the Jefferies Global ...
2 days ago Resolution Therapeutics Limited ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering engineered autologous macrophage cell …See details»
Resolution Therapeutics Announces Upcoming Scientific …
1 day ago Resolution Therapeutics Limited ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering engineered autologous macrophage cell …See details»
Resolution Therapeutics Announces Upcoming Scientific …
1 day ago Date and Time: Wednesday, June 5, 2024, 8:30 a.m. CEST. Presenter: Lara Campana, Ph.D., Vice President, Research Operations at Resolution Therapeutics. …See details»
Resolution Therapeutics - Crunchbase Company Profile & Funding
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases. An engineered autologous macrophage cell therapy …See details»
Introducing Resolution Therapeutics - YouTube
Dec 1, 2020 1. 263 views 3 years ago. A new Syncona company exploiting the wound healing ability of macrophages to stimulate organ repair following severe injury as a result of chronic disease. …See details»
Series A - Resolution Therapeutics - 2022-04-05 - Crunchbase
Apr 5, 2022 Resolution Therapeutics - Resolving inflammatory organ disease — Resolution Therapeutics Announces a £10m Extended Series A Financing from …See details»
Resolution Therapeutics | Pre-clinical companies | Portfolio
Resolution Therapeutics was founded by Syncona and is developing macrophage cell therapies to repair inflammatory organ damage.See details»
Resolution Therapeutics’ founders present clinical proof-of …
Nov 13, 2023 Edinburgh and London, UK, 13 November 2023 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company developing …See details»
Resolution Therapeutics - Updates, News, Events, Signals
Aug 18, 2023 Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.See details»
Resolution Therapeutics Announces a £26.6m Series A …
Feb 12, 2020 Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases characterised by …See details»
Resolution Therapeutics Announces Upcoming Scientific …
2 days ago Edinburgh and London, UK, 29 May 2024 – Resolution Therapeutics Limited (“Resolution” or “Company”), a clinical-stage biopharmaceutical company pioneering …See details»
Resolution Therapeutics - Funding, Financials, Valuation & Investors
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.See details»
Critical review of single-cell mechanotyping ... - RSC Publishing
3 days ago Accurate mechanical measurements of cells has the potential to improve diagnostics, therapeutics and advance understanding of disease mechanisms, where …See details»
Resolution Therapeutics Announces a £10m Extended Series A …
Apr 5, 2022 Resolution Therapeutics is a biotechnology company developing macrophage cell therapies to treat advanced liver disease. The Company is built upon …See details»
Resolution Therapeutics and CCRM sign collaboration …
Nov 7, 2022 Resolution Therapeutics is a biotechnology company developing macrophage cell therapies to treat advanced liver disease. The Company is built upon …See details»
Antimicrobial resistance: accelerating national and global responses
Document A77/5. “Antimicrobial resistance” refers to the resistance of bacterial, viral, parasitic and fungal microorganisms to antimicrobial medicines that were previously …See details»
Resolution Therapeutics’ founders present clinical proof-of …
Nov 13, 2023 In 2020, Professor Forbes co-founded Resolution Therapeutics, a biotech company focused on engineering macrophage cell therapies to deliver a more effective …See details»
Daily update: 29 May 2024 - World Health Organization (WHO)
1 day ago The Health Assembly approved a resolution to strengthen mental health and psychosocial support across all stages of emergencies, including conflicts, natural …See details»